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Leucine-Rich Repeat Kinase 2 
(Lrrk2)-Sensitive Na+/K+ ATPase 
Activity in Dendritic Cells
Zohreh Hosseinzadeh1,2,*, Yogesh Singh1,*, Derya R. Shimshek3, Herman van der Putten3,4, 
Carsten A. Wagner5 & Florian Lang1
Leucine-rich repeat kinase 2 (Lrrk2) has been implicated in the pathophysiology of Parkinson’s 
disease. Lrrk2 is expressed in diverse cells including neurons and dendritic cells (DCs). In DCs Lrrk2 was 
shown to up-regulate Na+/Ca2+-exchanger activity. The elimination of Ca2+ by Na+/Ca2+ -exchangers 
requires maintenance of the Na+ gradient by the Na+/K+ -ATPase. The present study thus explored 
whether Lrrk2 impacts on Na+/K+ -ATPase expression and function. To this end DCs were isolated 
from gene-targeted mice lacking Lrrk2 (Lrrk2−/−) and their wild-type littermates (Lrrk2+/+). Na+/K+ 
-ATPase activity was estimated from K+ induced, ouabain sensitive, current determined by whole cell 
patch clamp. Na+/K+ -ATPase α1 subunit transcript and protein levels were determined by RT-qPCR 
and flow cytometry. As a result, the K+ induced current was significantly smaller in Lrrk2−/− than in 
Lrrk2+/+ DCs and was completely abolished by ouabain (100 μM) in both genotypes. The K+ induced, 
ouabain sensitive, current in Lrrk2+/+ DCs was significantly blunted by Lrrk2 inhibitor GSK2578215A 
(1 μM, 24 hours). The Na+/K+ -ATPase α1 subunit transcript and protein levels were significantly lower 
in Lrrk2−/− than in Lrrk2+/+ DCs and significantly decreased by Lrrk2 inhibitor GSK2578215A (1 μM, 
24 hours). In conclusion, Lrrk2 is a powerful regulator of Na+/K+ -ATPase expression and activity in 
dendritic cells.
Leucine-rich repeat kinase 2 (Lrrk2) has been implicated in the pathophysiology of Parkinson’s disease (PD)1–3. 
Lrrk2 has further been speculated to participate in the pathophysiology of inflammatory bowel disease (IBD)4, 
leprosy5, and cancer6. Lrrk2 may be effective by regulating inflammatory processes7–9. Lrrk2 is expressed in sev-
eral circulating leukocytes, such as CD14+ monocytes, CD19+B cells, CD4+T cells and CD8+T cells10. Lrrk2 
is further expressed in dendritic cells (DCs)10,11, antigen-presenting cells linking innate and adaptive immu-
nity and contributing to stimulation of regulatory T cell differentiation, which impacts on the maintenance of 
self-tolerance12–15.
Lrrk2 contributes to signalling of interferon γ 11,16, NF-κ B-dependent transcription11 and regulation of reactive 
oxygen species (ROS) production11. Lrrk2 is up-regulated by bacterial lipopolysaccharide and lentiviral particles10 
and contributes to monocyte maturation17. Lrrk2 participates in the regulation of microglia inflammation and 
neurodegeneration18. However, cellular mechanisms accounting for Lrrk2 dependent pathophysiology of inflam-
mation and PD are still incompletely understood.
Lrrk2 is involved in Ca2+ signaling19. According to recent observations Lrrk2 up-regulates Na+/Ca2+ 
-exchanger expression and activity in DCs thus blunting Ca2+ -signals and attenuating Ca2+ -dependent functions 
of DCs20. Upregulation of Na+/Ca2+ -exchanger expression and activity could decrease cytosolic Ca2+ activity 
([Ca2+]i) only, if the electrochemical Na+ gradient is high enough to extrude Ca2+ against its steep electrochem-
ical gradient. Na+/Ca2+ -exchanger function thus requires maintenance of the Na+ gradient across the cell mem-
brane, a function of the Na+/K+ ATPase21. Inhibition of the Na+/K+ ATPase dissipates the Na+ gradient across 
the cell membrane, leads to reversal of the driving force of Na+/Ca2+ -exchange and thus increases [Ca2+]i22,23. To 
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the extent that a function of Lrrk2 is the stimulation of Ca2+ extrusion by up-regulation of Na+/Ca2+ -exchangers, 
the efficacy of the kinase requires adequate Na+/K+ ATPase activity. We hypothesized that Lrrk2 may, in addition 
to its effect on Na+/Ca2+ -exchange, up-regulate Na+/K+ ATPase activity.
The present study thus explored whether Lrrk2 participates in the regulation of Na+/K+ ATPase activity 
in DCs. DCs were isolated from gene-targeted mice lacking Lrrk2 (Lrrk2−/−) and their wild-type littermates 
(Lrrk2+/+) and Na+/K+ ATPase expression at mRNA and protein levels determined by RT-PCR and Western blot-
ting, respectively. Na+/K+ ATPase activity was measured by patch clamp. As a result, Na+/K+ ATPase expression 
and activity were indeed lower in Lrrk2−/− DCs than in Lrrk2+/+ DCs. Moreover, treatment of Lrrk2+/+ DCs with 
Lrrk2 inhibitor GSK2578215A decreased Na+/K+ ATPase activity. The up-regulation of Na+/K+ ATPase activity 
contributes to the maintenance of the steep electrochemical Na+ gradient required for Ca2+ extrusion by the Na+/
Ca2+ -exchanger.
Results
The present study explored, whether Lrrk2 has an impact on the Na+/K+ -ATPase activity in DCs. To this end 
ouabain sensitive K+ -induced outward currents were recorded utilizing whole cell patch clamp in DCs isolated 
from bone marrow of gene-targeted mice. Comparison was made between DCs isolated from mice lacking func-
tional Lrrk2 (Lrrk2−/−) and DCs isolated from their wild type littermates (Lrrk2+/+).
As shown in Fig. 1, the addition of 5 mM K+ to the bath solution was followed by an outward current, which 
was significantly smaller in DCs from Lrrk2−/− mice than in DCs from Lrrk2+/+mice. In both genotypes, the K+ 
induced current was abrogated by the addition of 100 μ M ouabain (Fig. 1A,B).
Further experiments explored whether genetic knockout of Lrrk2 was mimicked by pharmacological inhibi-
tion of the kinase by the Lrrk2 inhibitor GSK2578215A. As shown in Fig. 2, a 24 hours pre-treatment of Lrrk2+/+ 
DCs with GSK2578215A (1 μ M, 24 hours) was followed by a significant decrease of K+ induced current. In both, 
the presence and absence of GSK2578215A, the K+ induced current was abrogated by the addition of 100 μ M 
ouabain (Fig. 2A,B).
Figure 1. Na+/K+ -ATPase currents in Lrrk2−/− and Lrrk2+/+ DCs. (A) Original whole cell recordings at 
− 40 mV in Lrrk2+/+ DCs (upper) and Lrrk2−/− DCs (lower) in absence (Na+) and presence of 5 mM K+ (K+) 
in bath. K+ was added in absence (left) or presence (right) of ouabain (100 μ M). (B) Means ± SEM (n = 7-8) of 
whole-cell current at − 40 mV normalized to cell capacitance in Lrrk2+/+ DCs (white bar) and Lrrk2−/− DCs 
(black bar). ***(p < 0.001) indicates significant difference between genotypes, unpaired t-test.
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In order to test whether Lrrk2 influences Na+/K+ -ATPase at the transcript and/or protein level, transcript 
levels of the Na+/K+ -ATPase α 1 subunit were analyzed by RT-PCR and protein expression was analyzed using 
flow cytometry. As illustrated in Fig. 3A. the transcript levels of the Na+/K+ -ATPase α 1 subunit were significantly 
lower in Lrrk2−/− DCs than in Lrrk2+/+ DCs. Thus, in the absence of Lrrk2 Na+/K+ -ATPase transcript levels in 
DCs are reduced. Decreased transcript levels were accompanied by a reduction of Na+/K+ -ATPase α 1 subunit 
protein levels. Analysis using flow cytometry revealed that Na+/K+ -ATPase α 1 subunit protein abundance was 
lower in Lrrk2−/− DCs as compared to Lrrk2+/+ DCs (Fig. 3B,C).
Additional experiments explored whether pharmacological inhibition of the kinase by the Lrrk2 inhibitor 
GSK2578215A influences Na+/K+ -ATPase α 1 subunit expression. As illustrated in Fig. 4A, a 24 h treatment of 
Lrrk2+/+ DCs with GSK2578215A (1 μ M, 24 hours) resulted in a significant decrease of Na+/K+ -ATPase α 1 sub-
unit transcript levels and protein abundance of the Na+/K+ -ATPase α 1 subunit (Fig. 4B,C).
Discussion
The present observations demonstrate that Lrrk2 affects expression levels and activity of the Na+/K+ -ATPase 
in DCs. We show that Na+/K+ -ATPase activity is lower in DCs isolated from mice lacking functional Lrrk2 
(Lrrk2−/−) as compared to DCs isolated from wild type littermates (Lrrk2+/+). The down-regulation of Na+/K+ 
-ATPase activity in Lrrk2 deficient dendritic cells (DCs) is accompanied by a decrease in the level of Na+/K+ 
-ATPase α 1 subunit-encoding transcripts and of the Na+/K+ -ATPase α 1 subunit membrane protein.
The present observations do not allow safe conclusions concerning the mechanisms accounting for the 
decrease of Na+/K+ -ATPase α 1 subunit expression in Lrrk2 deficient DCs. However, it is noteworthy that Lrrk2 
influences the activity of several transcription factors. Lrrk2 up-regulates the activity of nuclear factor κ B (NF-κ B) 
by stimulation of expression and by phosphorylation of the inhibitor Iκ Bα 11,24,25. NF-κ B has in turn been shown 
to up-regulate the Na+/K+ -ATPase26. Lrrk2 further up-regulates the forkhead box transcription factor FoxO1 by 
direct phosphorylation27. Lrrk2 retains the transcription factor nuclear factor of activated T cells (NFAT) in the 
cytoplasma and Lrrk2 deficiency leads to nuclear up-regulation of NFAT28,29.
Figure 2. Sensitivity of Na+/K+ -ATPase currents in Lrrk2+/+ DCs to Lrrk2-inhibitor GSK2578215A.  
(A) Original whole cell recordings at − 40 mV in Lrrk2+/+ DCs in absence (Na+) and presence of 5 mM K+ (K+) 
in bath prior to (upper) and following (lower) 24 hours treatment with Lrrk2-inhibitor GSK2578215A (1 μ M) 
in absence (left) or presence (right) of ouabain (100 μ M). (B) Means ± SEM (n = 5–10) of whole-cell current at 
− 40 mV normalized to cell capacitance in Lrrk2+/+ DCs without (control; white bar) and with (1 μ M; black bar) 
a prior 24 hours exposure to Lrrk2-inhibitor GSK2578215A. ***(p < 0.001) indicates significant difference from 
absence of inhibitor, unpaired t-test.
www.nature.com/scientificreports/
4Scientific RepoRts | 7:41117 | DOI: 10.1038/srep41117
Figure 3. Lrrk2-dependent regulation of Na+/K+ -ATPase α1-subunit transcript and protein levels in 
Lrrk2−/−DCs and Lrrk2+/+ DCs. (A) Means ± SEM (n = 3) of α 1-subunit Na+/K+ -ATPase transcript levels in 
Lrrk2+/+ DCs (white bar) and Lrrk2−/− DCs (black bar) with Gapdh as reference (Lrrk2−/−DCs values normalized 
to Lrrk2+/+ DCs). (B) Original histogram of Na+/K+ -ATPase protein abundance determined by flow cytometry 
in Lrrk2+/+ DCs (red) and Lrrk2−/− DCs (blue). (C) Means ± SEM (n = 4) of Na+/K+ -ATPase protein abundance 
(mean fluorescence intensity; MFI) determined by flow cytometry in Lrrk2+/+ DCs (white) and Lrrk2−/− DCs 
(black). *(p < 0.05), **(p < 0.01) indicates significant difference between genotypes, unpaired t-test.
www.nature.com/scientificreports/
5Scientific RepoRts | 7:41117 | DOI: 10.1038/srep41117
A comparison of Na+/K+ -ATPase α 1 subunit expression (Figs 3 and 4) and Na+/K+ -ATPase activity (Figs 1 
and 2) suggests that Na+/K+ -ATPase α 1 subunit expression does not fully account for the differences in Na+/ 
K+ -ATPase activity. Thus, Lrrk2 may, in addition to its effect on expression, modify the activity of expressed Na+/
K+ -ATPase protein. In theory, Lrrk2 may directly phosphorylate the pump protein or may influence signalling 
Figure 4. Lrrk2-dependent Na+/K+ -ATPase α1-subunit transcript and protein levels in Lrrk2+/+ DCs 
without or with prior pharmacological inhibition of Lrrk2. (A) Means ± SEM (n = 3) of mRNA encoding 
Na+/K+ -ATPase α 1-subunit in Lrrk2+/+ DCs without (white) and with (black) prior exposure to the Lrrk2 
inhibitor GSK2578215A (1 μ M, 24 hours) with Gapdh as reference (treated normalized to respective untreated 
Lrrk2+/+ DCs). (B) Original histogram of Na+/K+ -ATPase protein abundance quantified by flow cytometry 
in untreated (red) and GSK2578215A (1 μ M, 24 hours) treated (blue) Lrrk2+/+ DCs. (D) Means ± SEM 
(n = 3) of Na+/K+ -ATPase protein abundance (mean fluorescence intensity; MFI) in untreated (white) and 
GSK2578215A (1 μ M, 24 hours) treated (black) Lrrk2+/+ DCs. *(p < 0.05) indicates significant difference from 
absence of inhibitor, unpaired t-test.
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molecules regulating Na+/K+ -ATPase activity. It is noteworthy that Lrrk2 activates the protein kinase B (PKB/
Akt)30, which shares the consensus sequence with serum and glucocorticoid inducible kinase SGK131, a kinase 
known to up-regulate Na+/K+ ATPase32.
The finding that Na+/K+ ATPase activity is significantly lower in Lrrk2−/− DCs than in Lrrk2+/+ DCs under 
baseline conditions suggests that Lrrk2 constitutively controls Na+/K+ ATPase activity. This is strongly supported 
by pharmacological inhibition of Lrrk2 in DCs. A 24 hours exposure of Lrrk2+/+ DCs to the Lrrk2 inhibitor 
GSK2578215A decreased Na+/K+ -ATPase expression and activity to a similar extent as the genetic knockout of 
the kinase in DCs. Collectively, these findings indicate that Lrrk2 kinase activity and expression in DCs accounts 
for the observed differences in DC Na+/K+ -ATPase activity
Downregulation of Na+/K+ -ATPase activity either by pharmacological agents33, a decrease in temperature34 
or energy depletion35, can lead to inhibition of K+ channels and result in cellular depolarization and dissipation 
of the electrical driving force for Na+ coupled transport36. Carriers affected by compromised Na+/K+ -ATPase 
activity include the Na+/Ca2+ exchangers37,38, which were previously shown to be regulated in a Lrrk2-dependent 
fashion20. Notably, Lrrk2 also affects Ca2+ signaling in neurons39 and in these excitable cells, depolarization due to 
down-regulation of Na+/K+ ATPase may modify cytosolic Ca2+ activity by activation of voltage gated Ca2+ chan-
nels40,41. To which extent Lrrk2-dependent Na+/K+ -ATPase activity and the activity of Na+/Ca2+ exchangers are 
linked, remains to be shown. In DCs, Lrrk2 clearly impacts on cytosolic Ca2+ activity, which participates in the 
regulation of diverse DC functions42 including maturation, synthesis of inflammatory cytokines and induction 
of oxidative burst39.
Na+/K+ -ATPase activity also impacts on cellular energy metabolism. The Na+/K+ ATPase is responsible for 
a large fraction (20–80%) of metabolic rate43 and accounts for about 30% of cellular ATP consumption44–47. In 
hypoxic microenvironments, such as inflammatory or tumor tissues48 the ability to regulate the Na+/K+ ATPase 
could therefore be relevant for DC survival, function and DC-mediated immune responses.
Another consequence of decreased Na+/K+ -ATPase activity might include increased cytosolic Na+ levels and 
an induction of salt-inducible kinase 1, which is a powerful stimulator of Na+/K+ ATPase and is part of a negative 
feedback loop regulating the Na+/K+ -ATPase49. In brief, future studies are needed to unravel the likely complex 
contribution on DC cell function of pump regulation by Lrrk2.
In conclusion, the present study demonstrates for the first time a Lrrk2 sensitive regulation of Na+/ 
K+ -ATPase expression and activity in bone marrow derived DCs. The impact of Lrrk2 on Na+/K+ -ATPase 
activity may affect multiple cellular functions in DCs and other cells and may be highly relevant in the pathophys-
iology of Lrrk2-pathway linked diseases.
Materials and Methods
Ethics Statement. All animal experiments were performed according to the German animal protection law 
and approved by the local authorities (Regierungspräsidium Tübingen).
Mice. Dendritic cells (DCs) were isolated from gene targeted mice lacking functional Lrrk2 (Lrrk2−/−) and 
their wildtype littermates (Lrrk2+/+). Origin of the mice, breeding and genotyping were described previously50. 
Male and female mice were studied at the age of 8–12 weeks. The mice had access to water ad libitum and to 
standard food (Altromin 1310).
Cell Culture. Dendritic cells (DCs) were cultured from bone marrow of 8–12 weeks old female and male 
Lrrk2+/+and Lrrk2−/− mice. Bone marrow derived cells were flushed out of the cavities from the femur and tibia 
with PBS51. Cells were then washed twice with RPMI and seeded out at a density of 2 × 106 cells per 60-mm dish. 
Cells were cultured for 7 days in RPMI 1640 with L-Glutamine (GIBCO, Carlsbad, Germany) containing: 10% 
FCS, 1% penicillin/streptomycin, 1% non-essential amino acids (NEAA) and 0.05% β -mercaptoethanol. Cultures 
were supplemented with GM-CSF (35 ng/mL, Immunotools, Germany) and fed with fresh medium contain-
ing GM-CSF on days 3 and 6. At day 7, > 95% of the cells expressed CD11c, which is a marker for mouse DCs. 
Experiments were performed on DCs at days 7–9.
Flow cytometry. Bone marrow derived DCs from Lrrk2−/− and Lrrk2+/+mice were characterised by 
using surface and intracellular staining with anti-Mouse CD11c-APC (eBiosciences; clone N418), anti-Mouse 
MHCII-PE (BD Biosciences; M5/114.15.2), rabbit anti-mouse-Na+/K+ ATPase α 1 subunit protein (Cell 
Signaling, USA) and Goat anti-Rabbit IgG-FITC (Santa Cruz Biotech, USA; sc-2012). To characterise the 
DCs, 200 × 103 BMDCs were collected and centrifuged at 600 g for 5 minutes at room temperature and washed 
once with 1x DPBS (Sigma, Germany). 0.5 μ l of antibody containing solution (0.2 μ g/μ l anti-CD11c-APC and 
anti-MHC II-PE) were added to 50 μ l of DPBS and cells were incubated for 30 minutes at room temperature in 
the dark. After incubation, cells were washed once with DPBS and fixed with 100 μ l of fixation/permeabilization 
buffer (eBioscience, Germany) for 30 minutes in the dark and washed once with 1x permeabilization buffer (eBi-
oscience, Germany). After washing, 0.5 μ l antibody containing solution (1.0 μ g/μ l anti-mouse-Na+/K+ ATPase 
α 1) was added to 50 μ l permeabilization buffer, cells were incubated in the dark for 45 minutes and cells were 
washed twice with 1x permeabilization buffer. After washing 0.2 μ l Goat anti-Rabbit IgG-FITC in 50 μ l of 1x per-
meabilization buffer was added and incubated for another 30 minutes in the dark. Finally, the cells were washed 
twice with DPBS and added 200 μ l of DPBS. All washing steps were performed at 600 g for 5 minutes and room 
temperature. Cells were acquired using BD FACSCalibur™ (BD Bioscience, Heidelberg, Germany) flow cytome-
try and data were analysed by Flowjo (Treestar, USA)53. CD11c+ DCs were gated for Na+/K+ ATPase α 1 protein 
expression, which is presented in mean fluorescence intensity (MFI).
Real-time PCR. Total RNA was extracted from mouse dendritic cells in PureLink™ RNA Mini Kit (Life 
Technologies, Germany) according to the manufacturer’s instructions54. Total RNA was used for cDNA synthesis 
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using Superscript III cDNA Synthesis kit (Life technologies, Germany) according to the manufacturer’s instruc-
tions. Polymerase chain reaction (PCR) amplification of the respective genes were set up in a total volume of 10 μ l 
using 10 ng of cDNA, 250 nM forward and reverse primer and 2x qPCR Master Mix KAPA SYBR Green (PeqLab, 
Erlangen, Germany) according to the manufacturer’s protocol. Cycling conditions were used as follows: initial 
denaturation at 95 °C for 3 min, followed by 40 cycles of 95 °C for 10 sec, 60 °C for 1 min and then melting curve 
analysis protocol was performed. For the amplification the following primers were used (5′ -> 3′ orientation): 
Atp1α 1 F: AGCATCAATGCGGAGGATGT, R: TATCCACCTTGCAGCCGTTT and Gapdh; F: CGT CCC GTA 
GAC AAA ATG GT; R: TTG ATG GCA ACA ATC TCC AC.
Specificity of PCR products was confirmed by analysis of melting curves. Real-time PCR amplifications were 
performed on a CFX96 Real-Time System (Bio-Rad). All experiments were done in duplicate. Amplification of 
the house-keeping gene GAPDH was performed to standardize the amount of sample RNA. Relative quantifica-
tion of gene expression was achieved using the ΔΔct method as described earlier55.
Patch clamp. Ouabain-sensitive K+ -induced currents (Ipump) reflecting Na+/K+ -ATPase activity were deter-
mined by whole cell patch clamp recording in Lrrk2−/− and Lrrk2+/+ DCs as well as in Lrrk2+/+ DCs in absence 
and presence of the LRRK2 inhibitor GSK2578215A (1 μ M, 24 hours) (Tocris, United Kingdom). Whole cell patch 
clamp experiments were performed at room temperature in voltage-clamp, fast whole cell mode56. Cells were 
continuously superfused through a flow system inserted into the dish. The bath was grounded via a bridge filled 
with the external solution. Borosilicate glass pipettes (2- to 4-MΩ resistance; Harvard Apparatus, UK) manu-
factured by a microprocessor-driven DMZ puller (Zeitz, Augsburg, Germany), were used in combination with 
a MS314 electrical micromanipulator (MW, Märzhäuser, Wetzlar, Germany). The currents were recorded by an 
EPC-9 amplifier (Heka, Lambrecht, Germany) and analyzed with Pulse software (Heka) and an ITC-16 Interface 
(Instrutech, Port Washington, NY). Currents were recorded at an acquisition frequency of 10 kHz and 3 kHz 
low-pass filtered57. To measure Na+/K+ ATPase activity, ouabain (100 μ M) sensitive K+ -induced outward cur-
rents were recorded53. The pipette solution contained (in mM): 30 NaCl, 20 KCl, 70 CsCl, 5 MgCl2, 5 HEPES, 5 
Na2ATP and 5 ethylene glycol tetraacetic acid (EGTA). The external solution contained (in mM) 60 NaCl, 80 
TEA-Cl, 1 MgCl2, 2.5 CaCl2, 5 NiCl2, 5 glucose, 10 HEPES (pH 7.4, CsOH), and 0.5 EGTA. Na+/K+ ATPase cur-
rents were elicited by switching to a bath solution that contained 60 NaCl, 80 TEA-Cl, 5 KCl, 1 MgCl2, 2.5 CaCl2, 
5 NiCl2, 5 glucose, 10 HEPES (pH 7.4, CsOH). The currents were measured at − 40 mV.
Statistical analysis. Data are provided as means ± SEM, n represents the number of independent experi-
ments. Data were tested for significance using unpaired student´s t-test. Results with p < 0.05 were considered 
statistically significant.
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